Tag: QT Vascular
Atherectomy included in pivotal study of QT Vascular’s Chocolate Touch DCB
The FDA has granted approval to include the use of atherectomy for lesion preparation in its ongoing US pivotal study of the Chocolate Touch...
“Promising” 12-month outcomes achieved with the Chocolate Touch drug-coated balloon
The final results of the ENDURE study, investigating the efficacy of the Chocolate Touch drug-coated balloon (QT Vascular), show “promising evidence of the drug...
Enrolment begins in US pivotal study of Chocolate Touch
QT Vascular has started enrolment in its US pivotal clinical study. The study will evaluate the company's Chocolate Touch drug-coated balloon (DCB), for use in...
QT Vascular enters into asset purchase option agreement with Medtronic
QT Vascular has entered into an asset purchase option agreement with Medtronic for the acquisition of the group's non-drug coated Chocolate percutaneous transluminal angioplasty...
Medtronic to distribute QT Vascular’s Chocolate balloon worldwide
QT Vascular has signed a definitive agreement with Medtronic, for the worldwide distribution of its Chocolate percutaneous transluminal angioplasty (PTA) catheter for a period...
US FDA grants QT Vascular full IDE approval for pivotal trial...
The US Food and Drug Administration (FDA) has granted QT Vascular full Investigational Device Exemption (IDE) approval to begin enrolling patients in the pivotal...
QT Vascular announces FDA approval to initiate pivotal trial of Chocolate...
The US Food and Drug Administration (FDA) has granted QT Vascular conditional Investigational Device Exemption (IDE) approval, allowing the company to begin enrolling patients...
